SC-24 IMPROVEMENT OF HUMAN MESENCHYMAL STEM CELL HOMING IN DELIVERY OF THERAPEUTIC AGENTS TO GLIOMA STEM CELL XENOGRAFTS

There is an urgent need to develop novel delivery methods for brain tumors. To this end, we have developed human bone marrow mesenchymal stem cells (MSCs) to overcome the problems associated with traditional therapeutic treatments. Compared with other cellular delivery systems, MSCs may be easily ac...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Pubblicato in:Neuro Oncol
Autori principali: Nilsson, Carol L., Wildburger, Norelle C., Gumin, Joy, Kroes, Roger A., Moskal, Joseph R., Mechref, Yehia, Lang, Frederick F.
Natura: Artigo
Lingua:Inglês
Pubblicazione: Oxford University Press 2014
Soggetti:
Abstracts
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC4218584/
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/neuonc/nou275.24
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi